Jasmohan S. Bajaj

Active 2007–2026

235
Papers
34,761
Citations
99
h-index
218
i10-index

Citations

Citations per year for Jasmohan S. Bajaj1985: 1 citations1996: 3 citations1997: 1 citations2001: 1 citations2002: 2 citations2004: 1 citations2005: 1 citations2007: 6 citations2008: 27 citations2009: 42 citations2010: 79 citations2011: 74 citations2012: 102 citations2013: 124 citations2014: 254 citations2015: 267 citations2016: 324 citations2017: 445 citations2018: 486 citations2019: 1,509 citations2020: 1,641 citations2021: 1,957 citations2022: 1,714 citations2023: 1,586 citations2024: 2,173 citations2025: 1,173 citations2026: 80 citations1986–1995: no citations, so these years are not shown1998–2000: no citations, so these years are not shown2003: no citations, so this year is not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,598 citing papers, 20.7% of this breakdownChina: 2,081 citing papers, 16.6% of this breakdownItaly: 714 citing papers, 5.7% of this breakdownUnited Kingdom: 664 citing papers, 5.3% of this breakdownSpain: 577 citing papers, 4.6% of this breakdownGermany: 513 citing papers, 4.1% of this breakdownFrance: 435 citing papers, 3.4% of this breakdownCanada: 414 citing papers, 3.3% of this breakdownIndia: 373 citing papers, 3% of this breakdownJapan: 277 citing papers, 2.2% of this breakdownAustralia: 247 citing papers, 2% of this breakdownSouth Korea: 232 citing papers, 1.8% of this breakdown
0%20.7%Other 27.3%

Fields

  • Medicine64.1%
  • Biochemistry, Genetics and Molecular Biology26.4%
  • Neuroscience1.6%
  • Immunology and Microbiology1.5%
  • Agricultural and Biological Sciences1.5%
  • Nursing1%
  • Other3.9%

Topics

  • Liver Disease Diagnosis and Treatment12.4%
  • Gut microbiota and health12.1%
  • Liver Disease and Transplantation10.6%
  • Organ Transplantation Techniques and Outcomes3.5%
  • Diet and metabolism studies3.4%
  • Clostridium difficile and Clostridium perfringens research3.4%
  • Other54.6%

Coauthors

All papers

Open in search
  1. Baveno VII – Renewing consensus in portal hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji - Journal of Hepatology 2021 cited by 2,669

  2. Bile acids and the gut microbiome

    Authors: , , , - Current Opinion in Gastroenterology 2014 cited by 1,316

  3. Alcohol, liver disease and the gut microbiota

    Authors: - Nature Reviews Gastroenterology & Hepatology 2019 cited by 685

  4. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

    Authors: , , , , , , , - Hepatology 2014 cited by 2,047

  5. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

    Authors: , , , , , , , , , , , , - Nature Communications 2020 cited by 399

  6. Altered profile of human gut microbiome is associated with cirrhosis and its complications

    Authors: , , , , , , , , , , , - Journal of Hepatology 2013 cited by 1,081

  7. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

    Authors: , , , , , , , , , , , , , , , , - Journal of Hepatology 2013 cited by 781

  8. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 622

  9. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder

    Authors: , , , , , , , , , , , - Hepatology 2020 cited by 254

  10. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy

    Authors: , , , , , , , - Journal of Hepatology 2020 cited by 460

  11. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial

    Authors: , , , , , , , , , , , , , , , , - Hepatology 2019 cited by 289

  12. The microbiota in cirrhosis and its role in hepatic decompensation

    Authors: , , , , - Journal of Hepatology 2021 cited by 254

  13. Targeting the gut-liver axis in liver disease

    Authors: , , , , - Journal of Hepatology 2017 cited by 423

  14. Promises of microbiome-based therapies

    Authors: , , - Journal of Hepatology 2022 cited by 111

  15. Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids

    Authors: , , , , , , , , , , , - Cell chemical biology 2018 cited by 209

  16. Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Gut 2022 cited by 105

  17. Acute-on-Chronic Liver Failure Clinical Guidelines

    Authors: , , , , , , - The American Journal of Gastroenterology 2022 cited by 234

  18. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 250

  19. The Evolving Challenge of Infections in Cirrhosis

    Authors: , , - New England Journal of Medicine 2021 cited by 205

  20. Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures

    Authors: , , , , , , , , , , , , - Hepatology 2014 cited by 573

  21. Linkage of gut microbiome with cognition in hepatic encephalopathy

    Authors: , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2011 cited by 550

  22. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 cited by 221

  23. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

    Authors: , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2012 cited by 529

  24. Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis

    Authors: , , , , , - Gastroenterology 2019 cited by 176